Task: Answer the multiple choice question.
Question: Which drug exhibits a -16.869% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CCC(C)n1nccc1NC(=O)C(C)OC(=O)c1cc2ccccc2[nH]1
b.) O=c1oc2ccccc2c(O)c1/C=C1\C=Nc2ccccc21
Answer: a. CCC(C)n1nccc1NC(=O)C(C)OC(=O)c1cc2ccccc2[nH]1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)n1nccc1NC(=O)C(C)OC(=O)c1cc2ccccc2[nH]1
CCC(C)n1nccc1NC(=O)C(C)OC(=O)c1cc2ccccc2[nH]1
[1-[(2-butan-2-ylpyrazol-3-yl)amino]-1-oxopropan-2-yl] 1H-indole-2-carboxylate